[1] Hu JP, Ye M, Zhou ZG. Aptamers: novel diagnostic and therapeutic tools for diabetes mellitus and metabolic diseases. J Mol Med, 2017; 95, 249−56. doi:  10.1007/s00109-016-1485-1
[2] Cefalu WT, Buse JB, Tuomilehto J, et al. Update and next steps for real-world translation of interventions for Type 2 diabetes prevention: reflections from a diabetes care editors’ expert forum. Diabetes Care, 2016; 39, 1186−201. doi:  10.2337/dc16-0873
[3] Zheng SR, Powell DW, Zheng F, et al. Diabetic nephropathy: proteinuria, inflammation, and fibrosis. J Diabetes Res, 2016; 2016, 5241549.
[4] Paul S, DeCastro AJ, Lee HJ, et al. Dietary intake of pterostilbene, a constituent of blueberries, inhibits the β-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats. Carcinogenesis, 2010; 31, 1272−8. doi:  10.1093/carcin/bgq004
[5] Bhakkiyalakshmi E, Sireesh D, Sakthivadivel M, et al. Anti-hyperlipidemic and anti-peroxidative role of pterostilbene via Nrf2 signaling in experimental diabetes. Eur J Pharmacol, 2016; 777, 9−16. doi:  10.1016/j.ejphar.2016.02.054
[6] Lee S, Lee MY, Nam JS, et al. Hemorheological approach for early detection of chronic kidney disease and diabetic nephropathy in type 2 diabetes. Diabetes Technol Ther, 2015; 17, 808−15. doi:  10.1089/dia.2014.0295
[7] Barutta F, Bruno G, Grimaldi S, et al. Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment. Endocrine, 2015; 48, 730−42. doi:  10.1007/s12020-014-0437-1
[8] Guan YF, Zhang YH, Breyer MD. The role of PPARs in the transcriptional control of cellular processes. Drug News Perspect, 2002; 15, 147−54. doi:  10.1358/dnp.2002.15.3.840011
[9] Qi HP, Wang Y, Zhang QH, et al. Activation of peroxisome proliferator-activated receptor γ (PPARγ) through NF-κB/Brg1 and TGF-β1 pathways attenuates cardiac remodeling in pressure-overloaded rat hearts. Cell Physiol Biochem, 2015; 35, 899−912. doi:  10.1159/000369747
[10] Qureshi AA, Guan XQ, Reis JC, et al. Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor. Lipids Health Dis, 2012; 11, 76. doi:  10.1186/1476-511X-11-76